Organic compounds -- part of the class 532-570 series – Organic compounds – Carbohydrates or derivatives
Reexamination Certificate
2007-07-26
2010-12-14
Jiang, Shaojia Anna (Department: 1623)
Organic compounds -- part of the class 532-570 series
Organic compounds
Carbohydrates or derivatives
C514S043000
Reexamination Certificate
active
07851617
ABSTRACT:
Novel indole derivatives of formula (I) or a pharmaceutically acceptable salt thereof:wherein R1is fluorine, or chlorine, and R2is hydrogen, or fluorine, which are SGLT inhibitors and are useful for treatment or prevention of diabetes and related conditions.
REFERENCES:
patent: 5424406 (1995-06-01), Tsujihara et al.
patent: 5731292 (1998-03-01), Tsujihara et al.
patent: 5830873 (1998-11-01), Tsujihara et al.
patent: 6414126 (2002-07-01), Ellsworth et al.
patent: 6515117 (2003-02-01), Ellsworth et al.
patent: 6562791 (2003-05-01), Maurya et al.
patent: 2001/0041674 (2001-11-01), Tomiyama et al.
patent: 2002/0052326 (2002-05-01), Washburn
patent: 2002/0111315 (2002-08-01), Washburn et al.
patent: 2003/0064935 (2003-04-01), Gougoutas
patent: 2003/0087843 (2003-05-01), Washburn
patent: 2003/0114390 (2003-06-01), Washburn et al.
patent: 2004/0053855 (2004-03-01), Fujikura et al.
patent: 2004/0063646 (2004-04-01), Fujikura et al.
patent: 2004/0110936 (2004-06-01), Ohsumi et al.
patent: 2004/0116357 (2004-06-01), Fushimi et al.
patent: 2004/0132669 (2004-07-01), Nishimura et al.
patent: 2004/0138143 (2004-07-01), Glombik et al.
patent: 2004/0259819 (2004-12-01), Frick et al.
patent: 2005/0014704 (2005-01-01), Frick et al.
patent: 2005/0032711 (2005-02-01), Patel et al.
patent: 2005/0032712 (2005-02-01), Urbanski
patent: 2005/0037980 (2005-02-01), Rybczynski et al.
patent: 2005/0037981 (2005-02-01), Beavers et al.
patent: 2006/0217323 (2006-09-01), Patel et al.
patent: 2006/0229260 (2006-10-01), Rybczynski et al.
patent: 2006/0234954 (2006-10-01), Urbanski
patent: 2006/0293251 (2006-12-01), Urbanski et al.
patent: 2007/0060545 (2007-03-01), Nomura et al.
patent: 2008/0119422 (2008-05-01), Nomura et al.
patent: 2494177 (2004-02-01), None
patent: 203-06 (2006-05-01), None
patent: 1528066 (2005-05-01), None
patent: 1 803 729 (2007-07-01), None
patent: 2001-288178 (2001-10-01), None
patent: 2003-12686 (2003-01-01), None
patent: WO-01/27128 (2001-04-01), None
patent: WO-01/68660 (2001-09-01), None
patent: WO-01/74834 (2001-10-01), None
patent: WO-01/74835 (2001-10-01), None
patent: WO-02/053573 (2002-07-01), None
patent: WO-02/068439 (2002-09-01), None
patent: WO-02/068440 (2002-09-01), None
patent: WO-02/083066 (2002-10-01), None
patent: WO-02/088157 (2002-11-01), None
patent: WO-03/011880 (2003-02-01), None
patent: WO-03/020737 (2003-03-01), None
patent: WO-03/099836 (2003-12-01), None
patent: WO-2004/007517 (2004-01-01), None
patent: WO-2004/013118 (2004-02-01), None
patent: WO-2004/014931 (2004-02-01), None
patent: WO-2004/019958 (2004-03-01), None
patent: WO-2004/0052902 (2004-06-01), None
patent: WO-2004/052903 (2004-06-01), None
patent: WO-2004/080990 (2004-09-01), None
patent: WO-2005/012326 (2005-02-01), None
patent: WO-2006/035796 (2006-04-01), None
R.H.Unger et al., Diabetologia, vol. 28, (1985), pp. 119-121.
Luciano Rossetti M.D. et al.,Diabetes Care, vol. 13, No. 6, (Jun. 1990), pp. 610-630.
Luciano Rossetti et al.,J. Clin. Invest., vol. 79, (May 1987), pp. 1510-1515.
Luciano Rossetti et al.,J. Clin. Invest.., vol. 80, (Oct. 1987), pp. 1037-1044.
Barbara B. Kahn et al.,J. Clin Invest., vol. 87, (Feb. 1991), pp. 561-570.
Kenji Tsujihara et al.,J. Med. Chem., vol. 42, (1999), pp. 5311-5324.
Kenji Arakawa et al.,British Journal of Pharmacology, vol. 132, (2001), pp. 578-586.
Ahmad et al.,Nucleosides, Nucleotides&Nucleic Acids, vol. 20, No. 9, (2001), pp. 1671-1682.
Zamani et al.,Journal of the Chinese Chemical Society, vol. 49, (2002), pp. 1041-1044.
Maatooq et al.,Phytochemistry, vol. 44, No. 1, (Jan. 1997), pp. 187-190.
Hongu et al., Chem. Pharm. Bull., vol. 46, No. 1, pp. 22-33, (1998).
Nomura Sumihiro
Sakamaki Shigeki
Birch & Stewart Kolasch & Birch, LLP
Bland Layla
Jiang Shaojia Anna
Mitsubishi Tanabe Pharma Corporation
LandOfFree
Indole derivatives does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Indole derivatives, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Indole derivatives will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4203671